P1357: IMPAIRED CELLULAR RESPONSES AGAINST SARS-COV-2 AFTER COVID-19 INFECTION IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

• A.-C. Mamez,
• A. Pradier,
• C. Stephan,
• F. Giannotti,
• S. Masouridi-Levrat,
• S. Morin,
• D. Neofytos,
• D.-L. Vu,
• A. Melotti,
• I. Arm,
• C. S. Eberhardt,
• J. Tamburini,
• L. Kaiser,
• Y. Chalandon,
• F. Simonetta

Affiliations

A.-C. Mamez

1 Division of Hematology, Department of Oncology

A. Pradier

1 Division of Hematology, Department of Oncology

C. Stephan

2 Département de médecine, unité de médecine transfusionnelle et d’immunohématologie

F. Giannotti

1 Division of Hematology, Department of Oncology

S. Masouridi-Levrat

1 Division of Hematology, Department of Oncology

S. Morin

1 Division of Hematology, Department of Oncology

D. Neofytos

3 Division of Infectious Diseases, Geneva University Hospitals

D.-L. Vu

3 Division of Infectious Diseases, Geneva University Hospitals

A. Melotti

4 Translational Research Centre in Onco-Haematology, Faculty of Medicine, University of Geneva

I. Arm

3 Division of Infectious Diseases, Geneva University Hospitals

C. S. Eberhardt

5 Center for Vaccinology

J. Tamburini

4 Translational Research Centre in Onco-Haematology, Faculty of Medicine, University of Geneva

L. Kaiser

6 Division of Infectious Diseases

Y. Chalandon

7 Division of Hematology, Department of Oncology, University Hospitals of Geneva, Geneva, Switzerland

F. Simonetta

7 Division of Hematology, Department of Oncology, University Hospitals of Geneva, Geneva, Switzerland